Tuesday September 16th
Phaedon Institute SenoTherapeutics Summit | |
08.30 - 09.15 | Registration |
09.15 - 09.25 | Welcome note (CNR/Chairs) |
09.25 - 12.25 | Session 1: New Discoveries, Biomarkers and Clinical Trials: a perspective from academics |
9:25-9:50 James Kirkland / UCLA - Targeting Cellular Senescence: the Translational Geroscience Network
9:50-10:15 Marissa Schafer / Mayo Clinic - Bridging Aging Biology and Intervention
10:15-10:40 Andrea Alimonti / IOR and ETH - Hunting Senescent Cells Through Targeted Immunotherapy
10:40-11:05 Clemens Schmitt / Johannes Kepler University - Activated by and cytotoxic through senescence-associated redox imbalance: A novel pan-senolytic that extends healthy lifespan and prevents Ras-/Braf-driven cancers
|
|
11:05 - 11:25 |
coffee break
|
11:25-11:50 Daohong Zhou / UT San Antonio - Using PROTAC to Develop Safer and Better BCL-XL/2 Targeting Senolytics for MAFLD/MASH
11:50-12:15 Frederick Beddingfield / Rubedo Life Sciences - A phase 1 study examining the impact of a novel topical GPX4 modulator and senolytic in inflammatory skin conditions and aging skin
|
|
12.15 - 12.50 |
Round table 1: Biomarkers and Clinical Trial Design for SenoTherapeutics
Frederick Beddingfield / Rubedo Life Sciences
James Kirkland / UCLA
Marissa Schafer / Mayo Clinic
Andrea Alimonti / IOR and ETH
Daohong Zhou / UT San Antonio
|
12.50 - 13.50 |
lunch break
|
13:50-14:15 Mike Sapieha / Unity Biotechnologies - UBX1325 in Diabetic Eye Disease
14:15-14:40 Alessandra Zatti / Chiesi Pharmaceuticals - Navigating Senotherapeutics in chronic lung diseases
|
|
14.40 - 15.05 |
“FederChimia - AssoBiotec" Round table 2: Cellular Senescence & Longevity Therapeutics: Are Big Pharma Ready to Bet on Aging Biology as key driver and mechanism of chronic diseases?
Benjamin Yaden / Eli Lilly
Alessandra Zatti / Chiesi Pharmaceutical
Alessandro Lattuada / Otsuka Pharmaceutical Italy
|
15.05 - 17.00 |
Session 2: Early-Stage Companies
15:05-15:30 Jia Xie / OneSkin - Development and Clinical Evaluation of OS-01 HAIR, a Senescence-Targeting Peptide Serum for Scalp Health
15:30-15:55 John Lewis / Oisin Biotechnologies - Systemic Senolysis and Functional Rejuvenation in Aged Mice via FAST-PLV Gene Therapy
|
15:55 - 16:15 |
coffee break
|
16:15 - 16:40 Kevin Slawin, MD / Phoenix SENOLYTIX - p16Ink4a - ATTAC Mouse Model: From Proof of Concept to Senolytic Gene Therapy to Increase Healthy Lifespan
16:40 - 17:05 Kevin Slawin, MD / Eos SENOLYTIX - Novel MitoXcel™ Geropeptides Demonstrate Features of Safe and Effective Gerotherapeutics
|
|
|
|
17:05 - 17:25 |
Senotherapeutics Biomarker Consortium (Marco Quarta/Marco Demaria)
|
17:25 - 18:00 |
Round table 3: From Gene Delivery to Immune Surveillance & Decentralized Discovery – Translating Senescence Science into the Next Generation of SenoTherapeutics
Paolo Binetti / VitaDAO
Kalon Boston, CBO / Minircle
Robin Mansukhani / Deciduous Therapeutics
|
18.00 - 18.15 |
Conclusions and final remarks
|
Wednesday September 17th
08.30 - 09:00 | Registration |
09.00 - 09:30 | Opening Remarks and ICSA history (Marco Demaria & Dot Bennett) |
09:30 - 10:40 |
Session 1 - Unraveling the SASP I 09:30-09:50 Bill Keyes (IGBMC) - Senescence as a Conserved Biological Program in Development, Aging, and Disease |
10:40 - 11:20 |
coffee break |
11:20 - 12:40 |
Session 2 - Viral induced senescence: 11:20-11:40 François Trottein (Institut Pasteur de Lille) - Ageing, cellular senescence and respiratory viral infections |
12:40 - 13:10 |
Flash talks I selected from abstracts (8 x 3 min) 1. Marco Malavolta (Advanced Technology Center for Aging Research and Geriatric Mouse Clinic, IRCCS) - Senolytic Strategies as Therapeutic Approaches for Frailty in Aging Mice |
13:10 - 15:00 |
Lunch + Poster Session 1 (even-numbered posters) |
15:00 - 16:40 |
Session 3 - Senescence as a player in myriad diseases 15:00-15:20 Marco Demaria (ERIBA) - TSPAN13 Orchestrates Senescence and Aging Through Integrin Signaling |
16:40 - 17:40 |
Keynote Speaker: Laura Niedernhofer |
18:15 - 20:30 |
Welcome Reception (off-site at La Limonaia, approx. 20 min walking) |
Thursday September 18th
09:00 - 10:40 |
Session 4 - Cellular mechanisms associated with senescence: from Metabolism, to Immunity, and Mitochondria 09:00-09:20 Eugenio Barone - From insulin signaling to mitochondrial fitness: metabolic pathways shaping brain aging |
10:40 - 11:20 |
coffee break |
11:20 - 12:30 |
Session 5 - Senescence and cancer 11:20-11:40 Valery Krizhanovsky (EKARD Institute for Cancer Diagnosis Research) - Senescent cells on the crossroads of cancer and aging |
12:30 - 13:00 |
Flash talks II selected from abstracts (7 x 3 min)
|
13:00 - 15:00 |
Lunch + Poster Session 2 (odd-numbered posters) |
15:00 - 16:50 |
Session 6 - Senescence in aging pathologies 15:00-15:20 Keiko Kono (OIST) - Plasma Membrane Damage Triggers Cellular Senescence, Linking Mechanical Stress to Age-related Pathologies |
17:00 - 18:00 |
yICSA Event (limited to early career researchers) - Feat. Rafaella Di Micco & Masashi Narita |
20:00 |
Gala Dinner & Party – Baja Roma |
Friday September 19th
09:30 - 11:10 |
Session 7 - Senescence pathways: From mechanism to therapeutic opportunity 09:30-09:40 Elia Cappuccio (University of Innsbruck) - Loss of FAHD1 mediates mitochondrial dysfunction: implications for cellular senescence |
11:10 - 11:50 |
coffee break |
11:50 - 12:50 |
General assembly, closure and poster prizes |
12:50 - 14:00 |
Lunch |
15:00 - 17:00 |
Optional guided tour of the historic City Center |